According to the report published by Market Research Store, the global Point-of-care glucose testing market size was valued at USD 3,351.29 Million in 2023 and is predicted to reach USD 4,804.04 Million by the end of 2032. The market is expected to grow with a CAGR of 4.05% during the forecast period. The report analyzes the global Point-of-care Glucose testing market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Point-of-care glucose testing market industry.
Global Point-of-care Glucose Testing Market: Overview
Point-of-care glucose testing is used to monitor diabetic patients, and they are also referred to as near-patient testing. Also, it has emerged as an efficient tool that helps manage patients, particularly in outpatient settings. However, the point-of-care glucose system device and electronic healthcare records help share the test results quickly with the medical providers. It also aids in reducing turnaround time and facilitating rapid decision-making abilities. It helps reverse life-threatening diseases like diabetic ketoacidosis, hypoglycemic seizures, and many others. However, the point-of-care glucose testing device is widely used in ICU.
Global Point-of-care Glucose Testing Market: Growth Factors
The global point-of-care glucose testing market is anticipated to expand with a considerable CAGR of 3.8% during the forecast period. One of the major reasons for the growth of the global point-of-care glucose testing market is the constantly growing geriatric population globally. Also, there is a significant spike in the number of diabetic patients across the globe, thereby expanding the scope of point-of-care glucose testing. According to the International Diabetes Federation, around 578 million people are likely to struggle with diabetes by 2030 and around 700 million by the end of 2045.
Additionally, the capability of POC diagnostic tests to produce quick results will further facilitate improved patient care. However, the scarcity of skilled staff is one of the other key factors propelling the growth of the global point-of-care glucose testing market. People are getting more aware of the proper diabetes management process and its associated benefits, thereby stimulating the demand for point-of-care glucose testing globally.
Global Point-of-care Glucose Testing Market COVID-19 Impact
The ongoing technological advancements and innovations focus on bringing more convenient and advanced featured products to the market; as a result, it is likely to throw strong growth prospects in the forthcoming years. Simultaneously, manufacturers are boosting their research and development activities along with increasing investment in research and operation activities.
However, the advent of the Covid-19 pandemic globally has positively impacted the growth of the global point-of-care glucose testing market as diabetes scaled up the risk of mortality from coronavirus infection. Therefore, the demand is likely to grow manifolds in the forthcoming years. However, the ongoing new product launches with improved capabilities are further strengthening the market growth exponentially.
Global Point-of-care Glucose Testing Market: Segmentation
The global point of care glucose testing market can be segmented into end-user, testing site, product, and region.
By end-user, the market can be segmented into home care settings, hospitals & clinics, professional diagnostic centers, and others. The home care setting segment accounts for the largest share in the global point of care glucose testing market due to the growing demand for cost-effective home health care devices. The ongoing technological advancements in these glucose-testing devices will further stimulate the growth of the segment.
By testing the site, the market can be segmented into alternate site testing and fingertip.
By product type, the market can be segmented into meters, lancets & lancing devices, and strips.
Point Of Care Glucose Testing Market: Report Scope
| Report Attributes |
Report Details |
| Report Name |
Point-of-care Glucose Testing Market Research Report |
| Market Size in 2023 |
USD 3,351.29 Million |
| Market Forecast in 2032 |
USD 4,804.04 Million |
| Growth Rate |
CAGR of 4.05% |
| Number of Pages |
196 |
| Key Companies Covered |
Johnson & Johnson, Quidel, PTS Diagnostic, PTS Diagnostic, Instrumentation Laboratories, Dickinson, Siemens Corporation, Becton, Nova Biomedical, Trividia Health, Ascensia Diabetes Care, Lifescan IP Holdings, LLC, Abbott, and Hoffmann-La-Roche Diabetes Care Ltd. |
| Segments Covered |
By End-user, By Testing site, By Product and By Region |
| Regions Covered |
North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year |
2023 |
| Historical Year |
2018 to 2022 |
| Forecast Year |
2024 - 2032 |
| Customization Scope |
Avail customized purchase options to meet your exact research needs. Request For Customization |
Global Point-of-care Glucose Testing Market: Regional Analysis
North America accounts for the largest share in the global point-of-care glucose testing market due to the presence of leading market players in the region. However, the easy availability of glucose testing products is likely to further contribute to the growth of the regional market. Also, the higher healthcare expense by the government on diabetes management will also strengthen the regional market.
Asia Pacific is likely to grow significantly during the forecast period due to the growing disposable income of the people in the region. Also, the constantly growing geriatric population and growing awareness among people regarding the availability of home care testing kits will further propel the growth of the regional market.
Global Point-of-care Glucose Testing Market: Competitive Players
Some of the significant players in the global point-of-care glucose testing market include:
- Johnson & Johnson
- Quidel
- PTS Diagnostic
- PTS Diagnostic
- Instrumentation Laboratories
- Dickinson, Siemens Corporation
- Becton
- Nova Biomedical
- Trividia Health
- Ascensia Diabetes Care
- Lifescan IP Holdings, LLC
- Abbott
- Hoffmann-La-Roche Diabetes Care Ltd.
Global Point-of-care Glucose Testing Market: Segment Analysis
By Product Type
- Meters
- Lancets & lancing devices
- Strips
By Testing the Site
- Alternate site testing
- Fingertip
By End-User
- Home care settings
- Hospitals & clinics
- Professional diagnostic centers
- Others
Global Point-of-care Glucose Testing Market: Regional Segment Analysis
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
What Reports Provide
- Full in-depth analysis of the parent market
- Important changes in market dynamics
- Segmentation details of the market
- Former, on-going, and projected market analysis in terms of volume and value
- Assessment of niche industry developments
- Market share analysis
- Key strategies of major players
- Emerging segments and regional markets
- Testimonials to companies in order to fortify their foothold in the market.
Table Of Content
Chapter 1. Preface
1.1 Report Description and Scope
1.2 Research scope
1.3 Research methodology
1.3.1 Market Research Type
1.3.2 Market research methodology
Chapter 2. Executive Summary
2.1 Global Point-of-care Glucose Testing Market, (2024 - 2032) (USD Million)
2.2 Global Point-of-care Glucose Testing Market : snapshot
Chapter 3. Global Point-of-care Glucose Testing Market - Industry Analysis
3.1 Point-of-care Glucose Testing Market: Market Dynamics
3.2 Market Drivers
3.2.1 The constantly growing geriatric population globally
3.3 Market Restraints
3.4 Market Opportunities
3.5 Market Challenges
3.6 Porter’s Five Forces Analysis
3.7 Market Attractiveness Analysis
3.7.1 Market attractiveness analysis By Product Type
3.7.2 Market attractiveness analysis By Testing the Site
3.7.3 Market attractiveness analysis By End-User
Chapter 4. Global Point-of-care Glucose Testing Market- Competitive Landscape
4.1 Company market share analysis
4.1.1 Global Point-of-care Glucose Testing Market: company market share, 2023
4.2 Strategic development
4.2.1 Acquisitions & mergers
4.2.2 New Product launches
4.2.3 Agreements, partnerships, cullaborations, and joint ventures
4.2.4 Research and development and Regional expansion
4.3 Price trend analysis
Chapter 5. Global Point-of-care Glucose Testing Market - Product Type Analysis
5.1 Global Point-of-care Glucose Testing Market overview: By Product Type
5.1.1 Global Point-of-care Glucose Testing Market share, By Product Type, 2023 and 2032
5.2 Meters
5.2.1 Global Point-of-care Glucose Testing Market by Meters, 2024 - 2032 (USD Million)
5.3 Lancets & lancing devices
5.3.1 Global Point-of-care Glucose Testing Market by Lancets & lancing devices, 2024 - 2032 (USD Million)
5.4 Strips
5.4.1 Global Point-of-care Glucose Testing Market by Strips, 2024 - 2032 (USD Million)
Chapter 6. Global Point-of-care Glucose Testing Market - Testing the Site Analysis
6.1 Global Point-of-care Glucose Testing Market overview: By Testing the Site
6.1.1 Global Point-of-care Glucose Testing Market share, By Testing the Site, 2023 and 2032
6.2 Alternate site testing
6.2.1 Global Point-of-care Glucose Testing Market by Alternate site testing, 2024 - 2032 (USD Million)
6.3 Fingertip
6.3.1 Global Point-of-care Glucose Testing Market by Fingertip, 2024 - 2032 (USD Million)
Chapter 7. Global Point-of-care Glucose Testing Market - End-User Analysis
7.1 Global Point-of-care Glucose Testing Market overview: By End-User
7.1.1 Global Point-of-care Glucose Testing Market share, By End-User, 2023 and 2032
7.2 Home care settings
7.2.1 Global Point-of-care Glucose Testing Market by Home care settings, 2024 - 2032 (USD Million)
7.3 Hospitals & clinics
7.3.1 Global Point-of-care Glucose Testing Market by Hospitals & clinics, 2024 - 2032 (USD Million)
7.4 Professional diagnostic centers
7.4.1 Global Point-of-care Glucose Testing Market by Professional diagnostic centers, 2024 - 2032 (USD Million)
7.5 Others
7.5.1 Global Point-of-care Glucose Testing Market by Others, 2024 - 2032 (USD Million)
Chapter 8. Point-of-care Glucose Testing Market - Regional Analysis
8.1 Global Point-of-care Glucose Testing Market Regional Overview
8.2 Global Point-of-care Glucose Testing Market Share, by Region, 2023 & 2032 (USD Million)
8.3. North America
8.3.1 North America Point-of-care Glucose Testing Market, 2024 - 2032 (USD Million)
8.3.1.1 North America Point-of-care Glucose Testing Market, by Country, 2024 - 2032 (USD Million)
8.4 North America Point-of-care Glucose Testing Market, by Product Type, 2024 - 2032
8.4.1 North America Point-of-care Glucose Testing Market, by Product Type, 2024 - 2032 (USD Million)
8.5 North America Point-of-care Glucose Testing Market, by Testing the Site, 2024 - 2032
8.5.1 North America Point-of-care Glucose Testing Market, by Testing the Site, 2024 - 2032 (USD Million)
8.6 North America Point-of-care Glucose Testing Market, by End-User, 2024 - 2032
8.6.1 North America Point-of-care Glucose Testing Market, by End-User, 2024 - 2032 (USD Million)
8.7. Europe
8.7.1 Europe Point-of-care Glucose Testing Market, 2024 - 2032 (USD Million)
8.7.1.1 Europe Point-of-care Glucose Testing Market, by Country, 2024 - 2032 (USD Million)
8.8 Europe Point-of-care Glucose Testing Market, by Product Type, 2024 - 2032
8.8.1 Europe Point-of-care Glucose Testing Market, by Product Type, 2024 - 2032 (USD Million)
8.9 Europe Point-of-care Glucose Testing Market, by Testing the Site, 2024 - 2032
8.9.1 Europe Point-of-care Glucose Testing Market, by Testing the Site, 2024 - 2032 (USD Million)
8.10 Europe Point-of-care Glucose Testing Market, by End-User, 2024 - 2032
8.10.1 Europe Point-of-care Glucose Testing Market, by End-User, 2024 - 2032 (USD Million)
8.11. Asia Pacific
8.11.1 Asia Pacific Point-of-care Glucose Testing Market, 2024 - 2032 (USD Million)
8.11.1.1 Asia Pacific Point-of-care Glucose Testing Market, by Country, 2024 - 2032 (USD Million)
8.12 Asia Pacific Point-of-care Glucose Testing Market, by Product Type, 2024 - 2032
8.12.1 Asia Pacific Point-of-care Glucose Testing Market, by Product Type, 2024 - 2032 (USD Million)
8.13 Asia Pacific Point-of-care Glucose Testing Market, by Testing the Site, 2024 - 2032
8.13.1 Asia Pacific Point-of-care Glucose Testing Market, by Testing the Site, 2024 - 2032 (USD Million)
8.14 Asia Pacific Point-of-care Glucose Testing Market, by End-User, 2024 - 2032
8.14.1 Asia Pacific Point-of-care Glucose Testing Market, by End-User, 2024 - 2032 (USD Million)
8.15. Latin America
8.15.1 Latin America Point-of-care Glucose Testing Market, 2024 - 2032 (USD Million)
8.15.1.1 Latin America Point-of-care Glucose Testing Market, by Country, 2024 - 2032 (USD Million)
8.16 Latin America Point-of-care Glucose Testing Market, by Product Type, 2024 - 2032
8.16.1 Latin America Point-of-care Glucose Testing Market, by Product Type, 2024 - 2032 (USD Million)
8.17 Latin America Point-of-care Glucose Testing Market, by Testing the Site, 2024 - 2032
8.17.1 Latin America Point-of-care Glucose Testing Market, by Testing the Site, 2024 - 2032 (USD Million)
8.18 Latin America Point-of-care Glucose Testing Market, by End-User, 2024 - 2032
8.18.1 Latin America Point-of-care Glucose Testing Market, by End-User, 2024 - 2032 (USD Million)
8.19. The Middle-East and Africa
8.19.1 The Middle-East and Africa Point-of-care Glucose Testing Market, 2024 - 2032 (USD Million)
8.19.1.1 The Middle-East and Africa Point-of-care Glucose Testing Market, by Country, 2024 - 2032 (USD Million)
8.20 The Middle-East and Africa Point-of-care Glucose Testing Market, by Product Type, 2024 - 2032
8.20.1 The Middle-East and Africa Point-of-care Glucose Testing Market, by Product Type, 2024 - 2032 (USD Million)
8.21 The Middle-East and Africa Point-of-care Glucose Testing Market, by Testing the Site, 2024 - 2032
8.21.1 The Middle-East and Africa Point-of-care Glucose Testing Market, by Testing the Site, 2024 - 2032 (USD Million)
8.22 The Middle-East and Africa Point-of-care Glucose Testing Market, by End-User, 2024 - 2032
8.22.1 The Middle-East and Africa Point-of-care Glucose Testing Market, by End-User, 2024 - 2032 (USD Million)
Chapter 9. Company Profiles
9.1 Johnson & Johnson
9.1.1 Overview
9.1.2 Financials
9.1.3 Product Portfolio
9.1.4 Business Strategy
9.1.5 Recent Developments
9.2 Quidel
9.2.1 Overview
9.2.2 Financials
9.2.3 Product Portfolio
9.2.4 Business Strategy
9.2.5 Recent Developments
9.3 PTS Diagnostic
9.3.1 Overview
9.3.2 Financials
9.3.3 Product Portfolio
9.3.4 Business Strategy
9.3.5 Recent Developments
9.4 PTS Diagnostic
9.4.1 Overview
9.4.2 Financials
9.4.3 Product Portfolio
9.4.4 Business Strategy
9.4.5 Recent Developments
9.5 Instrumentation Laboratories
9.5.1 Overview
9.5.2 Financials
9.5.3 Product Portfolio
9.5.4 Business Strategy
9.5.5 Recent Developments
9.6 Dickinson
9.6.1 Overview
9.6.2 Financials
9.6.3 Product Portfolio
9.6.4 Business Strategy
9.6.5 Recent Developments
9.7 Siemens Corporation
9.7.1 Overview
9.7.2 Financials
9.7.3 Product Portfolio
9.7.4 Business Strategy
9.7.5 Recent Developments
9.8 Becton
9.8.1 Overview
9.8.2 Financials
9.8.3 Product Portfolio
9.8.4 Business Strategy
9.8.5 Recent Developments
9.9 Nova Biomedical
9.9.1 Overview
9.9.2 Financials
9.9.3 Product Portfolio
9.9.4 Business Strategy
9.9.5 Recent Developments
9.10 Trividia Health
9.10.1 Overview
9.10.2 Financials
9.10.3 Product Portfolio
9.10.4 Business Strategy
9.10.5 Recent Developments
9.11 Ascensia Diabetes Care
9.11.1 Overview
9.11.2 Financials
9.11.3 Product Portfolio
9.11.4 Business Strategy
9.11.5 Recent Developments
9.12 Lifescan IP Holdings LLC
9.12.1 Overview
9.12.2 Financials
9.12.3 Product Portfolio
9.12.4 Business Strategy
9.12.5 Recent Developments
9.13 Abbott
9.13.1 Overview
9.13.2 Financials
9.13.3 Product Portfolio
9.13.4 Business Strategy
9.13.5 Recent Developments
9.14 Hoffmann-La-Roche Diabetes Care Ltd.
9.14.1 Overview
9.14.2 Financials
9.14.3 Product Portfolio
9.14.4 Business Strategy
9.14.5 Recent Developments
